ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY
批准号:
6625471
负责人:
Larry S. Sherman
金额:
$32.93万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-17 至 2004-11-30
关键词:
CD44 molecule Schwann cells cell differentiation cell proliferation enzyme activity genetically modified animals growth factor receptors intermolecular interaction laboratory mouse nerve injury nervous system regeneration neurogenesis neurotrophic factors peripheral nervous system protein tyrosine kinase wallerian degeneration
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The principle goal of the proposed studies is to elucidate the role of the CD44 family of transmembrane glycoproteins in perpheral nerves during development and following injury. Peripheral nerve development and maintenance require tightly regulated interactions between axons and Schwann cells. Schwann cell survival, proliferation and differentiation are influenced by axon-derived signals. One key signal is glial growth factor (GGF), which activates heterodimers of the receptor protein tyrosine kinases erbB2 and erbB3 in Schwann cells. GGF and its receptors have also been implicated in Wallerian degeneration, a process that occurs following nerve injury and which includes that induction of Schwann cell proliferation. The means by which GGF and related axon-derived signals promote erbB2-erbB3 heterodimerization and kinase activity are unclear. Our central hypothesis is that CD44 proteins are required for GGF signaling and in Schwann cell survival, proliferation and differentiation. CD44 has been implicated in cell-cell and cell- matrix interactions, and in growth factor presentation to high affinity cell surface receptors. Our preliminary data indicate the CD44 is essential for erbB2-erbB3 heterodimerization in Schwann cells, and that inhibition of CD44 expression results in Schwann cell apoptosis. We also found that CD44 is expressed in developing peripheral nerve at high levels when erbB2 expression is high and during active Schwann cell proliferation. We propose that CD44 acts by facilitating the interaction between axon- derived GGF and erbB receptors on the Schwann cell surface. We will test this notion experimentally with the following specific aims: (1) To ascertain whether CD44 acts as a low affinity GGF receptor; (2) To define the structural domains of CD44 that mediate interactions with ErbB2 and ErbB3 using cells expressing mutant CD44 proteins; (3) To determine if CD44 is required for Schwann cell survival, proliferation and/or differentiation during peripheral nerve development and Wallerian degeneration by comparing wild type mice and trasngenic mice whose Scwann cells lack CD44. Understanding how CD44 mediates the GGF-erbB2-erbB3 signaling complex will provide insight into the molecular mechanisms underlying normal peripheral nerve development, and may contribute significantly to our understanding of numerous conditions and diseases where axonal degeneration occurs, including nerve trauma, spinal cord injuries, and peripheral neuropathies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis
-
批准号:10346925
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2021
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY
-
批准号:8357753
-
项目类别:
-
资助金额:$4.36万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
COLLABORATIVE MS RESEARCH CENTER AWARD
-
批准号:8357887
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION
-
批准号:8357755
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
EVALUTATION OF HUMAN STEM CELL ENGRAFTMENT TO SHIVERER MICE
-
批准号:8357890
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF HYALURONAN INHIBITORS IN ETHANOL-INDUCED CHANGES IN NEUROGENESIS
-
批准号:8357886
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
THERAPEUTIC REMYELINATION STRATEGIES IN A NOVEL MODEL OF MS
-
批准号:8357821
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
NOVEL HYALURONIDASE INHIBITORS FOR THE PROMOTION OF REMYELINATION
-
批准号:8357867
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
TARGETING NEUROTROPHIC FACTOR RECEPTORS TO BLOCK PAIN IN SCHWANNOMATOSIS
-
批准号:8357885
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
WHITE MATTER DAMAGE IN AGE-RELATED COGNITIVE DECLINE
-
批准号:8357822
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
EFFECTS OF ETHANOL EXPOSURE ON HYALURONAN-MEDIATED ADULT NEUROGENESIS
-
批准号:8357865
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY
-
批准号:8173210
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF SNF5 IN SCHWANN CELL TUMORIGENENSIS
-
批准号:8173279
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION
-
批准号:8173212
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
VASCULAR ENDOTHELIUM-DERIVED FACTORS IN STURGE-WEBER SYNDROME HYPERMYELINATION
-
批准号:8173278
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
TARGETING HYALURONIDASES AS A STRATEGY TO REVERSE REMYELINATION FAILURE
-
批准号:8173316
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
EVALUATION OF THE SAFETY & EFFICACY OF AN IMPLANTED BIODEGRADABLE SCAFFOLD
-
批准号:8173320
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
THERAPEUTIC REMYELINATION STRATEGIES IN A NOVEL MODEL OF MS
-
批准号:8173318
-
项目类别:
-
资助金额:$9.51万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF SW1/SNF FACTORS IN SCHWANNOMATOSIS ASSOCIATED PAIN
-
批准号:8173317
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION
-
批准号:8173192
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
海外基金